Showing 1741-1750 of 5789 results for "".
Pros and Cons of DTC Advertising
https://practicaldermatology.com/topics/practice-management/pros-and-cons-of-dtc-advertising/18569/Hilary Baldwin, MD and James Q. Del Rosso, DO sit down with Derm Insider Host Neal Bhatia, MD to weigh the pros and cons of direct-to-consumer advertising on patients. They agree that if done well and with a primary focus on disease state rather than a specific drug, these ads can encourage patientsAdvocating for Dermatology
https://practicaldermatology.com/topics/practice-management/advocating-for-dermatology/18578/Host Neal Bhatia, MD sits down with two dermatologists with a great deal of experience advocating for the field — Terrence A. Cronin Jr, MD and Lawrence J. Green, MD. They share insights into how advocacy arms like SkinPAC and the Advisory Board committee of the American Academy of Dermatology work.Patient Outreach Initiatives; Erelzi Approved
https://practicaldermatology.com/topics/practice-management/dermwiretv-patient-outreach-initiatives-erelzi-approved---etudruli/18580/DermatologistOnCall® Partners with NPF to enhance access to care for psoriasis. Vivacare Partners with NRS for patient education. Erelzi from Sandoz approved as biosimilar to Enbrel. And the FDA bans antibacterial ingredients from hand soaps; Calls for plain soap and water hand washing.Update on Pediatric Vulvar Lichen Sclerosis
https://practicaldermatology.com/topics/general-topics/update-on-pediatric-vulvar-lichen-sclerosis/18733/Pediatric vulvar lichen sclerosis may be under-recognized. Pediatric dermatologist Kalyan Marathe, MD talks to host Adam Friedman, MD about the importance of identifying and treating the condition, providing relief to patients and potentially avoiding unnecessary testing.Topical Toxins: Now and Later
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-toxins-now-and-later/18768/Topical neurotoxins are in late-stage development, with the potential to offer "softer" results and reduction of fine wrinkles. But they may not be approved for another few years. In the meantime, micro channel delivery of toxins, such as with AquaGold, is an option. Joel Schlessinger, MD, founder oNextech: A Specialized, All-in-One Solution
https://practicaldermatology.com/topics/general-topics/nextech-a-specialized-all-in-one-solution/18919/Specialty practices don't need canned solutions to their EMR needs, says dermatologist Saif Sayed of Skincare Specialty Physicians. He left a general EMR for Nextech, which provides "rich capability" to customize the EHR to his practice needs and his approach to patient care. From streamlining officSkin cancer: Coach's toughest opponent: PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-coach-s-toughest-opponent-psa/18922/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The PSA and video feature Division I college women's basketball coach Lisa Pace, who blames her indoor tanning habit for the development of more than 80 skin cancers, five ofGuys, Don't Be Like Paul:Â PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/guys-don-t-be-like-paul-psa/18924/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The first PSA and video focuses specifically on men and features Dr. Keaney. Data from the Skin Cancer Foundation cited by ASDS show that only 30 percent of American men areDefining the Physician-Patient Relationship
https://practicaldermatology.com/topics/practice-management/defining-the-physician-patient-relationship/18928/In this edition of Derm Insider, Allan Wirtzer, MD and Cliff Lober, MD, JD talk to host Neal Bhatia, MD about the importance of defining the physician-patient relationship, determining when the relationship is established, and understanding the legal implications that come with that fiduciary or heiUnwinding Psoriasis Comorbidities
https://practicaldermatology.com/topics/psoriasis/unwinding-psoriasis-comorbidities/18936/Ronald Prussick, MD assesses the state of psoriasis treatment, with a particular focus on comorbidities. He also sums up new pivotal data on comborbitities that may shift the treatment spectrum.